Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > A move all Oncy shareholders need to make, to screw the shor

<< Previous

Bullboard Posts

Next >>

Comment by CMHarring218431on Apr 29, 2024 12:29pm

114 Views

Post# 36012859

RE:RE:A move all Oncy shareholders need to make, to screw the shor

Another simple way to keep your shares from being lent out to shorters is to call your broker and put in an order to sell your shares at like six dollars. Then your shares cannot be borrowed by shorters

<< Previous

Bullboard Posts

Next >>

Get a better understanding of the psychology of options trading